| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Is Required for Oleic Acid-Induced Secretion of Glucagon-Like Peptide-1 by Intestinal Endocrine L CellsDepartments of Physiology (R.I., A.I., A.Y., P.L.B.) and Medicine (C.I.W., P.L.B.), University of Toronto, Toronto, Ontario, Canada M5S 1A8; and Department of Internal Medicine I (R.I.), Merheim Medical Center, D-51109 Cologne, Germany
Address all correspondence and requests for reprints to: Dr. P. L. Brubaker, Room 3366 Medical Sciences Building, University of Toronto, 1 Kings College Circle, Toronto, Ontario, Canada M5S 1A8. E-mail: p.brubaker{at}utoronto.ca.
Long-chain, monounsaturated fatty acids (FAs) stimulate secretion of the incretin hormone, glucagon-like peptide-1 (GLP-1) from the intestinal L cell. Because the atypical protein kinase C (PKC), PKC
, is involved in FA signaling in many cells, the role of PKC
in FA-induced GLP-1 secretion was investigated, using the murine GLUTag L cell line and primary rat intestinal L cells. GLUTag cells expressed mRNA for several PKC isoforms, including PKC
, and PKC
protein was localized throughout the cytoplasm in GLUTag and primary L cells as well as normal mouse and rat L cells. Treatment with oleic acid (1501000 µM) for 2 h increased GLP-1 secretion (P < 0.001), and this was abrogated by the PKC
inhibitor ZI (P < 0.05) and PKC
small interfering RNA transfection (P < 0.05) but not inhibition of classical/novel PKC isoforms. Although most PKC
was localized in the particulate compartment of GLUTag cells, oleate treatment did not alter PKC
levels or activity in this cell fraction. GLUTag cells expressed mRNA for the Gq-coupled FA receptor GPR120; however, oleic acid did not induce any changes in Akt, MAPK, or calcium, and pretreatment with LY294002 and PD98059 to inhibit phosphatidylinositol 3-kinase and MAPK, respectively, did not prevent the effects of oleic acid. Finally, GLUTag cells also released GLP-1 in response to arachidonic acid (P < 0.001) but were not affected by other long-chain FAs. These findings demonstrate that PKC
is required for oleic acid-induced GLP-1 secretion. This enzyme may therefore serve as a therapeutic target to enhance GLP-1 release in type 2 diabetes.
This article has been cited by other articles:
![]() |
L. Lauffer, R. Iakoubov, and P. L. Brubaker GPR119: "Double-Dipping" for Better Glycemic Control Endocrinology, May 1, 2008; 149(5): 2035 - 2037. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |